SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ariella who wrote (1122)8/7/1998 11:08:00 AM
From: Zvi Steinberg  Read Replies (2) of 1491
 
Here's from CBS Stock Watch:

" "The company I'm about to mention, an Israeli biotechnology stock no less, has
been a holding of mine for about six months. And I'm continuing to add to
my position. It's Pharmos Corp. (PARS): interesting company with two
products already approved by the U.S. Food & Drug Administration,
revenues from these products this past quarter, and a drug in Phase II
human trials that is based on, a-hem, cannabis. First, there are the two
strong ophthalmic products approved by the FDA: Lotemax and Alrex.
And this cannibis derivative, HU-211 (Hebrew University 211) is into
Phase II with strong outcomes behind it. And the stock, perhaps due to
lack of Wall Street awareness (and) justifiable suspicion of anything
biotechnological is languishing." So says C. Maher, who last checked in
with us when he discussed prospects for Internet company Infoseek."

cbs.marketwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News